Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours

被引:0
|
作者
S. A. Veltkamp
H. Rosing
A. D. R. Huitema
M. R. Fetell
A. Nol
J. H. Beijnen
J. H. M. Schellens
机构
[1] The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital,Division of Experimental Therapy
[2] The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
[3] The Netherlands Cancer Institute/Slotervaart Hospital,Department of Pharmacy and Pharmacology
[4] University of Utrecht,Division of Biomedical Analysis, Faculty of Pharmaceutical Sciences
[5] Ivax Research,undefined
[6] Inc.,undefined
来源
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词
Phase I; Pharmacokinetics; Paclitaxel; Cremophor-free; Oral administration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:635 / 642
页数:7
相关论文
共 50 条
  • [41] A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours
    Adjei, A. A.
    Beg, M.
    Melear, J.
    Thompson, J.
    Tsai, F. Y-C.
    Baranda, J. C.
    Bastos, B.
    Spira, A.
    Lou, Y.
    Seetharam, M.
    Uemura, M.
    Camidge, D. R.
    Yamamoto, N.
    Cowey, C. L.
    Doi, T.
    Anthony, S. P.
    Janat-Amsbury, M.
    Wade, M.
    Bearss, D. J.
    Sarantopoulos, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S469 - S469
  • [42] Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
    Razak, A. R. A.
    Hotte, S. J.
    Siu, L. L.
    Chen, E. X.
    Hirte, H. W.
    Powers, J.
    Walsh, W.
    Stayner, L-A
    Laughlin, A.
    Novotny-Diermayr, V.
    Zhu, J.
    Eisenhauer, E. A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 756 - 762
  • [43] Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    Harries, M
    O'Donnell, A
    Scurr, M
    Reade, S
    Cole, C
    Judson, I
    Greystoke, A
    Twelves, C
    Kaye, S
    BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1651 - 1655
  • [44] A phase I/II study of DHP107, a novel oral paclitaxel formulation, in patients with advanced solid tumors (phase I) and gastric cancer (phase II).
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Kim, Tae Won
    Kim, Sung-Bae
    Lim, Hyeong-Seok
    Bae, Kyun-Seop
    Park, Sook Ryun
    Jo, Yeong-Woo
    Cho, Hyun Ju
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [45] Phase I and Pharmacokinetic Study of Sequential Paclitaxel and Trabectedin Every 2 Weeks in Patients with Advanced Solid Tumors
    Chu, Quincy
    Mita, Alain
    Forouzesh, Bahram
    Tolcher, Anthony W.
    Schwartz, Gary
    Nieto, Antonio
    Soto-Matos, Arturo
    Alfaro, Vicente
    Lebedinsky, Claudia
    Rowinsky, Eric K.
    CLINICAL CANCER RESEARCH, 2010, 16 (09) : 2656 - 2665
  • [46] A PHARMACOKINETIC STUDY OF ORAL PACLITAXEL IN COMBINATION WITH HM30181 IN SOLID CANCER PATIENTS
    Kim, S. E.
    Gu, N.
    Shin, D.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S36 - S36
  • [47] Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours
    Ruth Plummer
    Henk M. Verheul
    Filip Y. F. L. De Vos
    Karin Leunen
    L. Rhoda Molife
    Christian Rolfo
    Peter Grundtvig-Sørensen
    Jacques De Grève
    Sylvie Rottey
    Guy Jerusalem
    Antoine Italiano
    James Spicer
    Luc Dirix
    Carsten Goessl
    Joseph Birkett
    Stuart Spencer
    Maria Learoyd
    Christopher Bailey
    Emma Dean
    Advances in Therapy, 2018, 35 : 1945 - 1964
  • [48] Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours
    Plummer, Ruth
    Verheul, Henk M.
    De Vos, Filip Y. F. L.
    Leunen, Karin
    Molife, L. Rhoda
    Rolfo, Christian
    Grundtvig-Sorensen, Peter
    De Greve, Jacques
    Rottey, Sylvie
    Jerusalem, Guy
    Italiano, Antoine
    Spicer, James
    Dirix, Luc
    Goessl, Carsten
    Birkett, Joseph
    Spencer, Stuart
    Learoyd, Maria
    Bailey, Christopher
    Dean, Emma
    ADVANCES IN THERAPY, 2018, 35 (11) : 1945 - 1964
  • [49] Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
    de Jonge, M. J. A.
    Dumez, H.
    Kitzen, J. J. E. M.
    Beuselinck, B.
    Verweij, J.
    Courtney, R.
    Battista, A.
    Brega, N.
    Schoffski, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1328 - 1335
  • [50] Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours
    de Jonge, MJA
    Verweij, J
    van der Gaast, A
    Valota, O
    Mora, O
    Planting, AST
    Mantel, MA
    Van den Bosch, S
    Lechuga, MJ
    Fiorentini, F
    Hess, D
    Sessa, C
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (18) : 2407 - 2415